Site Search
Search Results
16th Annual ACS CAN Research and Health Equity Breakfast
... organization working every day to make issues facing cancer patients a national and state priority. Advancing Research, Innovation and Health Equity 1 in 2 men and 1 in 3 women in the United States will be diagnosed with cancer in their lifetime. As can cer prevention, early detection technology, targeted and immuno-therapies advance, we must also advance health equity so that all people have a fair and just opportunity to live longer, healthier lives free from cancer. Join us for the 16 th Annual ... Health Equity Breakfast on September 29th from 7:30-9:30am at 521 Overlook at Fenway Park, where we convene leaders from life sciences, health care, government, academia, and businesses to network and discuss how we can work together to accelerate research and innovation, and advance ...
Reigniting Research: A Call to Action to Advance Cancer Research and Innovation
... innovation saves lives and stimulates the economy. The COVID-19 pandemic has disrupted research and clinical trials. The National Institutes of Health (NIH), stands to lose $10 billion worth of currently funded research due to the pandemic. The breakthroughs we are seeing in cancer ... of investment in basic science. The loss of currently funded research would have negative consequences for cancer patients and the public health community for years to come. Simply put: cancer patients would pay for the loss of disrupted research with their lives. Investing in Medical Research Catalyzes Scientific Discovery: Eliminating cancer relies as much on public policy as it does on science and care. While policymakers are addressing acute needs related to COVID-19, cancer patients need policies that accelerate cures. ACS CAN is ...
15th Annual ACS CAN Research and Health Equity Breakfast
... organization working every day to make issues facing cancer patients a national and state priority. Advancing Research, Innovation and Health Equity 1 in 2 men and 1 in 3 women in the United States will be diagnosed with cancer in their lifetime. As can cer prevention, early detection technology, targeted and immuno-therapies advance, we must also advance health equity so that all people have a fair and just opportunity to live longer, healthier lives free from cancer. Join us for the 15 th Annual ... on October 14th from 7:30-9:30am at the Boston Marriott Cambridge in Kendall Square, where we convene leaders from life sciences, health care, government, academia, and businesses to network and discuss how we can work together to accelerate research and innovation, and advance ...
ACS CAN 2018 New England Research Breakfast
... a matter of public policy as it is scientific discovery. Whether it is increasing cancer research and prevention funding or improving access to health coverage, ACS CAN protects the needs of patients and families , working to ensure that our innovation ecosystem remains strong and everyone has the access to care they need to prevent, detect, and fight cancer. Now in its 11 th year, the annual ACS CAN New England Research Breakfast brings ... Harvard Medical School Tracy Battaglia, MD Associate Professor of Medicine and Epidemiology at Boston University Schools of Medicine and Public Health Joan Reede, MD —Honoree Dean for Diversity and Community Partnership Harvard Medical School Mallika Marshall, MD —Emcee Health Reporter, ...
ACS CAN 2019 New England Research Breakfast
... a matter of public policy as it is scientific discovery. Whether it is increasing cancer research and prevention funding or improving access to health coverage, ACS CAN protects the needs of patients and families , working to ensure that our innovation ecosystem remains strong and everyone has the access to care they need to prevent, detect, and fight cancer. Now in its 12 th year, the annual ACS CAN New England Research Breakfast brings ... Thank you to our sponsors. Diamond Presenting Sponsor Gold Sponsor Silver Sponsors AbbVie AstraZeneca BeiGene Beth Israel Lahey Health Boston Children's Hospital Bristol-Myers Squibb Dana-Farber Cancer Institute Foundation Medicine ImmunoGen, Inc MassBio MIT Koch Institute ...